DHR NYSE Week ended 24 Jul 2026

Weekly Investor Report

Danaher Corporation · Healthcare · Diagnostics & Research

Open interactive chart View report data Download investor PDF
Latest close 191.5 USD
-6.0% latest week
Weekly setup

Weak trend

The weekly trend is not active. Price is -2.5% below the Trend Line and sits at 38.1% of its 52-week range. The latest completed week returned -6.0%, after a -2.4% four-week move. The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is expensive relative to peers. Options positioning is bullish with 40/100 conviction, while the latest news-sentiment score is 54/100. Near-term considerations: earnings are due in 82d.

Setup score 52 out of 100
Latest Close 191.5 USD 24 Jul 2026
1W Return -6.0% latest completed week
4W Return -2.4% short-term follow-through
12W Return 9.6% quarterly tape
Trend Breadth 38.5% 20 of 52 weeks active
Volume Ratio 2.6x vs 13-week average
What is working
  • Activity pressure is positive on the latest completed week.
  • Volume is elevated versus the 13-week average, confirming attention.
  • Next-week expectancy is positive at 56.48% based on similar historical setup states.
What could go wrong
  • The trend backdrop is inactive, so price action has not confirmed a constructive regime.
  • Price is below the Trend Line, which keeps downside pressure in focus.
  • Price is below Fair Value, so the market is still discounting the latest tape.
  • Activity pressure is weak, so confirmation is not yet broad enough.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through -6.0% Latest completed week; four-week move -2.4%. Indicator stack 21/97 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Recent Activity-pressure buy-signal status for institutional accumulation timing. Next-Week Expectancy Positive 56.48% Historical one-week expectancy contributes to the evidence score when direction is confirmed. Options pressure Bullish 40/100 conviction; expected move 4.6%. News sentiment 54/100 45 relevant articles in the latest sentiment read. Event risk 82d Next report is scheduled for 20 Oct 2026; event risk rises as the date approaches.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is not active. Price is -2.5% below the Trend Line and sits at 38.1% of its 52-week range. The latest completed week returned -6.0%, after a -2.4% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 2.6x the 13-week average. Participation is unusually strong and confirms that the move is attracting attention.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
30 Jan 6 Feb 13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.1612-week average 0.05

12-week confirmation

Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure5/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.16Current proprietary activity-pressure read.
Buy signals1Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers

No recent accumulation markers. No reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is -2.4% over four weeks, 9.6% over 12 weeks, and -6.1% over one year. The current trend has remained active for 0 consecutive weeks.

Performance by holding period

1W-6.0%
4W-2.4%
12W9.6%
26W-18.2%
52W-6.1%
Active trend streak0 weeks
Active weeks in one year20
Trend breadth38.5%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure0.79Latest activity-pressure read.
Pressure change408.9%Four-week change in activity pressure.
Leadership-12.62Latest relative-leadership reading.
RS change-19.7%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is expensive relative to peers.

Open full factor analysis
Factor week 26 Jul 2026 Financial statements through 31 Dec 2025 Field coverage 97% Model confidence 97%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength14/100Blend of value, momentum, and quality. Underlying universe rank 87; rank 1 is best.
Value10/100Relative valuation strength. Underlying universe rank 91; rank 1 is best.
Quality80/100Profitability and accounting quality. Underlying universe rank 21; rank 1 is best.
Momentum24/100Medium-term price momentum. Underlying universe rank 77; rank 1 is best.
Growth22/100Revenue and earnings growth. Underlying universe rank 79; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Value-quality framework33/100Value and quality alignment from the Sharemaestro SVQF framework.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
33.6x
Price divided by trailing earnings.
Price / sales
5.4x
Market value relative to trailing revenue.
EV / EBITDA
24.4x
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
5.0%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
58.5%
Gross profit retained from each unit of revenue.
Operating margin
19.9%
Operating profit retained from revenue.
Free-cash-flow margin
31.1%
Free cash flow generated from revenue.
Return on invested capital
5.6%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
4.6%
Latest one-year revenue growth.
EPS growth
17.3%
Latest one-year earnings-per-share growth.
Free-cash-flow growth
4.4%
Latest one-year free-cash-flow growth.
Piotroski F-score
6/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
0.8%
Cash dividends relative to market value.
Buyback yield
2.1%
Net share repurchases relative to market value.
Shareholder yield
2.8%
Dividend yield plus net buyback yield.
Net debt / EBITDA
3.5x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Options positioningBullish

DHR shows bullish options pressure with a 40/100 conviction score, put-call volume ratio of 0.45, expected move of 4.6%, and Sharemaestro trend signal inactive.

Conviction40/100
Expected move4.6%
Put/call volume0.45
Pressure41
Speculation44
Volatility53
Trend agreement30
Open options detail
Insider activity14 / 6

14 acquisitions and 6 disposals in the latest 180-day insider tape.

Acquisitions / disposals over the latest 180 days. Insider activity is context, not a stand-alone signal.
News sentiment54/100

Weighted news tone is neutral across 45 relevant articles.

13 positive · 29 neutral · 3 negative
Patient CapitalRecent

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

Recent buy signal in the last 8 weeks
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings82dNext report is scheduled for 20 Oct 2026; event risk rises as the date approaches.
Options expected move4.6%Nearest-chain priced movement where available.
52-week drawdown-20.8%Distance below the 52-week high.
13-week volatility4.6%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher11 of 2615 weeks finished lower.
Best week+11.0%Week of 26 Jun.
Worst week-9.0%Week of 24 Apr.
Latest week-6.0%Week of 24 Jul.

Shape of recent returns

Strong gains4
Modest gains7
Flat weeks0
Modest losses9
Sharp losses6
Recent vol4.6%13-week weekly-return volatility.
Base vol4.6%52-week weekly-return volatility.
Up/down split24/28Count of positive and negative weeks in the 52-week window.
Average skew3.6% / -3.2%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape50/100

Trend, activity pressure, participation, and risk combine to a 50/100 tape read.

 Indicator analysis20/100

Latest 12-week confirmation: trend 0/12, activity pressure 5/12, relative leadership 0/12.

Activity pressure 0.16; No reversal markers Next-Week ExpectancyPositive 56.48%

Next-week expectancy is positive with a 56.48% historical one-week setup read.

Adds short-term historical context without overriding trend, activity, or relative leadership. Factors31/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 23 SVQF33/100

Value and quality alignment from the Sharemaestro SVQF framework.

Composite rank 681.5 of 1013 Patient CapitalRecent

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

Recent buy signal in the last 8 weeks Options50/100

DHR shows bullish options pressure with a 40/100 conviction score, put-call volume ratio of 0.45, expected move of 4.6%, and Sharemaestro trend signal inactive.

Bullish · Call-side pressure · Expected move 4.6% Sentiment54/100

Weighted news tone is neutral across 45 relevant articles.

Danaher Corp (DHR) Valuation: PE, PB & Fair Value Analysis Insiders14 / 6

14 acquisitions and 6 disposals in the latest 180-day insider tape.

 Earnings82d

Next report is scheduled for 20 Oct 2026; event risk rises as the date approaches.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
24 Jul 2026191.5 USD-6.0%196.4 USD219.5 USD0.79-12.6263.6MOff
17 Jul 2026203.8 USD2.4%197.7 USD219.7 USD0.78-7.9320.7MOff
10 Jul 2026199.1 USD0.6%198.3 USD219.8 USD0.53-11.6516.9MOff
3 Jul 2026197.9 USD0.9%199.2 USD219.9 USD0.35-11.3215.5MOff
26 Jun 2026196.2 USD11.0%200.1 USD219.9 USD0.16-10.5425.7MOff
19 Jun 2026176.8 USD-1.6%201.1 USD220.0 USD-0.22-21.5716.7MOff
12 Jun 2026179.7 USD-2.3%202.7 USD220.2 USD-0.43-20.0218.9MOff
5 Jun 2026183.9 USD0.9%204.0 USD220.4 USD-0.66-18.1820.6MOff
29 May 2026182.3 USD6.2%204.9 USD220.5 USD-0.89-21.3219.3MOff
22 May 2026171.7 USD6.2%205.9 USD220.6 USD-1.05-25.2222.1MOff
15 May 2026161.6 USD-5.4%207.6 USD220.8 USD-1.02-29.3927.6MOff
8 May 2026170.8 USD-2.3%209.1 USD221.1 USD-1.00-25.7224.6MOff
1 May 2026174.8 USD-1.2%210.2 USD221.2 USD-1.05-22.7025.3MOff
24 Apr 2026176.9 USD-9.0%211.5 USD221.5 USD-1.02-21.5635.6MOff
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.